期刊文献+

血清脂肪细胞型脂肪酸结合蛋白与冠心病及其危险因素的相关性 被引量:1

Association of Serum Adipocyte Fatty Acid Binding Proteins with Coronary Artery Disease and Its Risk Factors
下载PDF
导出
摘要 目的研究血清脂肪细胞型脂肪酸结合蛋白水平与冠心病及其危险因素之间的相关性,探讨其对冠心病及血管病变程度的预测价值。方法经冠状动脉造影选取340名患者,用病变血管支数和Gensini积分表示冠状动脉病变程度,酶联免疫吸附法测定血清脂肪细胞型脂肪酸结合蛋白水平。结果血清脂肪细胞型脂肪酸结合蛋白水平在三支病变组[18.6(13.8~24.0)μg/L]高于非冠心病组[16.4(13.5~20.4)μg/L,P<0.05]及单支病变组[17.5(13.5~20.3)μg/L,P<0.05];女性[20.0(16.9~23.9)μg/L]明显高于男性[15.4(12.5~20.3)μg/L,P=0.000];总体冠心病组血清脂肪细胞型脂肪酸结合蛋白水平[18.3(13.2~22.8)μg/L]较非冠心病组[16.4(13.5~20.4)μg/L]升高,但差异无统计学意义(P=0.088)。女性冠心病组血清脂肪细胞型脂肪酸结合蛋白[22.8(18.6~25.7)μg/L]明显高于非冠心病组[18.1(15.6~21.8)μg/L,P<0.01]。血清脂肪细胞型脂肪酸结合蛋白与Gensini积分呈正相关(男性r=0.105,P<0.05;女性r=0.405,P<0.01),多元回归分析发现血清脂肪细胞型脂肪酸结合蛋白与女性Gensini积分有独立相关性(P=0.018)。血清脂肪细胞型脂肪酸结合蛋白与甘油三酯(r=0.187,P<0.01)、空腹血糖(r=0.115,P<0.01)、高敏C反应蛋白(r=0.135,P<0.05)等心血管危险因素呈明显正相关,与高密度脂蛋白胆固醇(r=-0.168,P<0.01)及载脂蛋白A1(r=-0.126,P<0.05)呈明显负相关。结论血清脂肪细胞型脂肪酸结合蛋白可能成为预测人类冠心病及血管病变程度的有用指标,它是女性冠心病的独立危险因素,可能对糖代谢及脂代谢有一定影响。 Aim To measure the serum adipocyte fatty acid binding protein (A-FABP) levels in patients with and without coronary artery disease (CAD),trying to investigate the relationship between A-FABP and severity of coronary stenosis,risk factors of CAD.Methods The study cohort included 340 subjects who underwent coronary angiography.The severity of coronary artery stenosis was assessed by the numbers of involved coronary artery branches and the sum of the Gensini scores.Serum A-FABP levels were determined by enzyme-linked immuneosorbent assays.Results The levels of serum A-FABP were significantly higher in patients with three vessel lesions (18.6(13.8~24.0)μg/L) than those with single vessel lesion (17.5(13.5~20.3) μg/L,P〈0.05) and those with non-lesions (16.4(13.5~20.4) μg/L,P〈0.05).CAD patients tend to have higher A-FABP levels (18.3(13.2~22.8) μg/L) than non-CAD subjects (16.4(13.5~20.4) μg/L),but the difference did not reach statistical significance (P=0.088).Women had higher serum A-FABP level than men (20.0(16.9~23.9)vs 15.4(12.5~20.3)μg/L,P〈0.05) and the difference in A-FABP were statistically significant between CAD patients and controls in females(22.8(18.6~25.7)μg/L vs 18.1(15.6~21.8) μg/L).Serum A-FABP levels were positively correlated with Gensini scores in both men (r=0.105,P〈0.05) and women (r=0.405,P〈0.01).Multiple linear regression analysis showed that serum A-FABP level was independently associated with Gensini scores in women (P=0.018),but not in man.A-FABP positively associated with triglyceride (TG)(r=0.187,P〈0.01),fasting blood-glucose (FBG)(r=0.115,P〈0.01) and high sensitivity C-reaction protein (hs-CRP)(r=0.135,P〈0.05),and inversely with high density lipoprotein cholesterol (HDLC) (r=-0.168,P〈0.01) and apolipoprotein(ApoA1)(r=-0.126,P〈0.05).Conclusion Serum A-FABP levels could reflect the extent of coronary artery atherosclerosis,and it is associated with CAD more closely in females than in males.A-FABP might participate in glucose and lipid metabolic disorders.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2009年第10期851-854,共4页 Chinese Journal of Arteriosclerosis
关键词 冠心病 脂肪细胞型脂肪酸结合蛋白 血清 危险因素 Coronary Artery Disease Adipocyte Fatty Acid Binding Protein Serum Risk Factor .
  • 相关文献

参考文献12

  • 1Hotamisligil GS, Johnson RS, Distel R J, et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein [J]. Science, 1996, 274 (5291) : 1 377-379.
  • 2Makowski L, Boord JB, Maeda K, et al. Lack of macrophage fatty-acidbinding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis [J]. Nat Med, 2001,7 (6) : 699-705.
  • 3Boord JB, Maeda K, Makowski L, et al. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosls, and survival in apolipoprotein E-deficient mice [J]. Circulation, 2004, 110 (11) : 1 492-498.
  • 4Furuhashi M, Tuncman G, Gorgun CZ, et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 [J]. Nature, 2007, 447 (7147) : 959-965.
  • 5Gensini G. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol, 1983,51 (3):606.
  • 6Xu A, Tso AW, Cheung BM, et al. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5- year prospective study [J]. Circulation, 2007, 115 (12) : 1 537-543.
  • 7国家“九五”科技攻关课题协作组,武阳丰(整理),周北凡(整理),李莹(整理).我国中年人群心血管病主要危险因素流行现状及从80年代初至90年代末的变化趋势[J].中华心血管病杂志,2001,29(2):74-79. 被引量:461
  • 8郑昕,李建军,郭远林,慕朝伟,张朝阳,高展,戴军.45岁以下女性冠心病患者危险因素及冠状动脉造影特点分析[J].中国动脉硬化杂志,2007,15(10):769-772. 被引量:9
  • 9Tuncman G, Erbay E, Hom X, et al. A genetic variant at the fatty acid- binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease [J]. Proc Natl Acad Sci USA, 2006, 103 (18) : 6 970-975.
  • 10Yeung DC, Xu A, Cheung CW, et al. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis [J]. Arterioscler Thromb Vasc Biol, 2007, 27 (8) : 1 796-802.

二级参考文献17

共引文献468

同被引文献23

  • 1Cabr A, Lazaro I, Girona J, et al. Plasma fatty acid binding protein4 is associated with atherogenic dyslipidemia in diabetes [J]. J Lipid Res, 2008, 49(8):1746-1751.
  • 2Rhee EJ, Lee WY, Park CY, et al. The association of serumadipocyte fatty acid-binding protein with coronary artery disease in Korean adults[J]. Eur J Endocrinol, 2009,160(2):165-172.
  • 3Lamounier-Zepter V, Look C, et al. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease[J]. Circ Res, 2009, 14;105(4):326-34.
  • 4L am D C, Xu A, L am K S, et al. Serum adipocyte fatty acid binding protein level is elevated in severe OSA and correlate with insulin resistance [J]. Eur Respir J, 2009,33:346-351.
  • 5王凤娟,范献良等,阻塞性睡眠呼吸暂停综合征患者血清脂肪细胞脂肪酸结合蛋白水平的检测及分析Determination and analysis of adipocyte fatty acid binding protein in serum of patients, vithobstructive sleep apnea syndrome.[J].山东大学,2010,5.
  • 6GillilanRE, AyersSD, et al. NoyN. Structural basis for activation of fatty acid-binding protein 4. J Mol Biol, 2007, 372(5): 1246-60.
  • 7Chmurzyfi ska A. et al. The multigene family of fatty acid binding p rotein (FABPs) : Fuction, structure and polymorphism [J]. J Appl Genent, 2006,47 (1) : 39-48.
  • 8Aim in X, YuW, J ian Y X, et al. A dipocyte fatty acid binding protein is a plasm a biota arker closely associated with obesity and metabolic syndrom e [J]. Clinical Chemistry, 2006, 52:405-413.
  • 9ElmasriH, KaraaslanC, et al. Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells [J]. FASEB J, 2009 Nov;23(11):3865-73.
  • 10Chmurzyfi ska A. et al. The multigene family of fatty acid binding p rotein ( FABPs): Fuction, structure and polymorphism [J]. J Appl Genent, 2006,47 (1): 39-48.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部